Jeffrey Wang

Jeffrey Wang is a Research Analyst at RTW Investments, Lp, based in New York, NY, where he has served since June 2011. His responsibilities center on fundamental research and investment analysis within the healthcare and life sciences sectors, leveraging his scientific and industry background to identify and evaluate innovative biotechnology and pharmaceutical opportunities. At RTW Investments, Wang focuses on therapeutics, medical devices, and healthcare technologies, supporting the firm's mission to invest in high-impact, science-driven ventures.

Prior to joining RTW Investments, Wang was affiliated with Merck, where he gained industry experience that informs his current investment analysis work. His career at RTW coincides with the firm’s emphasis on biotechnology and healthcare innovation, making him a key contributor to sourcing and evaluating sector-leading companies.

Wang holds a degree from Cornell University's S.C. Johnson Graduate School of Management, in addition to academic credentials from Shanghai Jiao Tong University and the University of Florida. His expertise spans both scientific and financial domains, contributing to RTW’s reputation for rigorous due diligence and sector expertise. He is recognized for his analytical approach and his role in advancing investments that address critical unmet medical needs.